Education
About Us
Working with TipRanks
Follow Us
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF
Total Valuation
ONO Pharmaceutical Co has a market cap or net worth of $7.78B. The enterprise value is $1.14T.
Market Cap$7.78B
Enterprise Value$1.14T
Share Statistics
ONO Pharmaceutical Co has 498,692,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding498,692,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ONO Pharmaceutical Co’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.32%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.32%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee126.36M
Profits Per Employee15.40M
Employee Count3,853
Asset Turnover0.46
Inventory Turnover1.98
Valuation Ratios
The current PE Ratio of ONO Pharmaceutical Co is 21.0. ONO Pharmaceutical Co’s PEG ratio is -0.25.
PE Ratio21.0
PS Ratio1.55
PB Ratio0.96
Price to Fair Value0.96
Price to FCF10.12
Price to Operating Cash Flow―
PEG Ratio-0.25
Income Statement
In the last 12 months, ONO Pharmaceutical Co had revenue of 486.87B and earned 50.05B in profits. Earnings per share was 106.55.
Revenue486.87B
Gross Profit338.92B
Operating Income59.75B
Pretax Income59.33B
Net Income50.05B
EBITDA91.54B
Earnings Per Share (EPS)106.55
Cash Flow
In the last 12 months, operating cash flow was 82.46B and capital expenditures -5.43B, giving a free cash flow of 77.03B billion.
Operating Cash Flow82.46B
Free Cash Flow77.03B
Free Cash Flow per Share154.46
Dividends & Yields
ONO Pharmaceutical Co pays an annual dividend of $0.254, resulting in a dividend yield of 4.16%
Dividend Per Share$0.254
Dividend Yield4.16%
Payout Ratio81.64%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.46
52-Week Price Change98.32%
50-Day Moving Average14.13
200-Day Moving Average11.78
Relative Strength Index (RSI)89.22
Average Volume (3m)1.67K
Important Dates
ONO Pharmaceutical Co upcoming earnings date is May 13, 2026, TBA (Confirmed).
Last Earnings DateFeb 2, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
ONO Pharmaceutical Co as a current ratio of 3.07, with Debt / Equity ratio of ―
Current Ratio3.07
Quick Ratio2.56
Debt to Market Cap0.18
Net Debt to EBITDA-0.63
Interest Coverage Ratio11.23
Taxes
In the past 12 months, ONO Pharmaceutical Co has paid 9.16B in taxes.
Income Tax9.16B
Effective Tax Rate0.15
Enterprise Valuation
ONO Pharmaceutical Co EV to EBITDA ratio is 7.60, with an EV/FCF ratio of 9.34.
EV to Sales1.43
EV to EBITDA7.60
EV to Free Cash Flow9.34
EV to Operating Cash Flow8.44
Balance Sheet
ONO Pharmaceutical Co has $210.38B in cash and marketable securities with $132.00B in debt, giving a net cash position of $63.70B billion.
Cash & Marketable Securities$210.38B
Total Debt$132.00B
Net Cash$63.70B
Net Cash Per Share$127.74
Tangible Book Value Per Share$929.10
Margins
Gross margin is ―, with operating margin of 12.27%, and net profit margin of 10.28%.
Gross Margin―
Operating Margin12.27%
Pretax Margin12.19%
Net Profit Margin10.28%
EBITDA Margin18.80%
EBIT Margin13.28%
Analyst Forecast
The average price target for ONO Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―